1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2. Research Methodology
2.1. Objective of the
Study
2.2. Baseline Methodology
2.3. Key Industry
Partners
2.4. Major Association
and Secondary Sources
2.5. Forecasting
Methodology
2.6. Data Triangulation
& Validation
2.7. Assumptions and
Limitations
3. Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, and Trends
4.
Voice of Customer
5. Global Nuclear
Pharmacy Market Outlook
5.1.
Market Size & Forecast
5.1.1. By Value
5.2.
Market Share & Forecast
5.2.1. By Type (Institutional and Commercial)
5.2.2. By Purpose (Diagnostic and Therapeutic)
5.2.3. By Company (2022)
5.2.4. By Region
5.3.
Product Market Map
6. North America Nuclear
Pharmacy Market Outlook
6.1.
Market Size & Forecast
6.1.1. By Value
6.2.
Market Share & Forecast
6.2.1. By Type
6.2.2. By Purpose
6.2.3. By Country
6.3.
North America: Country Analysis
6.3.1. United States Nuclear
Pharmacy Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Type
6.3.1.2.2.
By Purpose
6.3.2. Mexico Nuclear
Pharmacy Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Type
6.3.2.2.2.
By Purpose
6.3.3. Canada Nuclear
Pharmacy Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Type
6.3.3.2.2.
By Purpose
7. Europe Nuclear
Pharmacy Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value
7.2.
Market Share & Forecast
7.2.1. By Type
7.2.2. By Purpose
7.2.3. By Country
7.3.
Europe: Country Analysis
7.3.1. France Nuclear
Pharmacy Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Type
7.3.1.2.2.
By Purpose
7.3.2. Germany Nuclear
Pharmacy Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Type
7.3.2.2.2.
By Purpose
7.3.3. United Kingdom Nuclear
Pharmacy Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Type
7.3.3.2.2.
By Purpose
7.3.4. Italy Nuclear
Pharmacy Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Type
7.3.4.2.2.
By Purpose
7.3.5. Spain Nuclear
Pharmacy Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Type
7.3.5.2.2.
By Purpose
8. Asia-Pacific Nuclear
Pharmacy Market Outlook
8.1.
Market Size & Forecast
8.1.1. By Value
8.2.
Market Share & Forecast
8.2.1. By Type
8.2.2. By Purpose
8.2.3. By Country
8.3.
Asia-Pacific: Country Analysis
8.3.1. China Nuclear
Pharmacy Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Type
8.3.1.2.2.
By Purpose
8.3.2. India Nuclear
Pharmacy Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Type
8.3.2.2.2.
By Purpose
8.3.3. South Korea Nuclear
Pharmacy Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Type
8.3.3.2.2.
By Purpose
8.3.4. Japan Nuclear
Pharmacy Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Type
8.3.4.2.2.
By Purpose
8.3.5. Australia Nuclear
Pharmacy Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Type
8.3.5.2.2.
By Purpose
9. South America Nuclear
Pharmacy Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value
9.2.
Market Share & Forecast
9.2.1. By Type
9.2.2. By Purpose
9.2.3. By Country
9.3.
South America: Country Analysis
9.3.1. Brazil Nuclear
Pharmacy Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Type
9.3.1.2.2.
By Purpose
9.3.2. Argentina Nuclear
Pharmacy Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Type
9.3.2.2.2.
By Purpose
9.3.3. Colombia Nuclear
Pharmacy Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Type
9.3.3.2.2.
By Purpose
10. Middle East and
Africa Nuclear Pharmacy Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Type
10.2.2. By Purpose
10.2.3. By Country
10.3.
MEA: Country Analysis
10.3.1. South Africa Nuclear
Pharmacy Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Type
10.3.1.2.2.
By Purpose
10.3.2. Saudi Arabia Nuclear
Pharmacy Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Type
10.3.2.2.2.
By Purpose
10.3.3. UAE Nuclear Pharmacy
Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Type
10.3.3.2.2.
By Purpose
11.
Market Dynamics
11.1.
Drivers
11.1.1. Increasing
Prevalence of Chronic Diseases.
11.1.2. Technological
Advancements in Various Treatments
11.1.3. Surge in Research
and Development
11.2.
Challenges
11.2.1.
High Cost of Treatment
11.2.2. Side Effects of
Drugs
12. Market Trends & Developments
12.1.
Product Launches
12.2.
Mergers & Acquisitions
12.3.
Technological Advancements
13. Clinical Trial
Analysis
13.1.
Global Nuclear pharmacy Market: SWOT Analysis
14.
Market Trends & Developments
15.
Competitive Landscape
15.1.
GE Healthcare
15.1.1. Business Overview
15.1.2. Product Offerings
15.1.3. Recent Developments
15.1.4. Financials (In Case
of Listed Companies)
15.1.5. Key Personnel
15.1.6. SWOT Analysis
15.2.
Jubilant Radiopharma (Jubilant Pharma Holdings Inc.)
15.3.
Cardinal Health, Inc.
15.4.
ARTMS Inc.
15.5.
AnazaoHealth Corp.
15.6.
SOFIE
15.7.
Pacific Radiopharmacy, Ltd.
15.8.
NTP Radioisotopes SOC Ltd.
15.9.
Lantheus Medical Imaging, Inc.
15.10.
The Australian Nuclear Science and Technology Organization
16. Strategic Recommendations
17. About Us & Disclaimer